Ministry of Health ServicesGoverment of British Columbia
Pharmacare Program
| Home | SA Criteria | SA Forms | RDP | LCA |
Non Steroidal Anti Inflammatory Drugs - Special Authority Criteria

Generic Name / Strength / Form
flurbiprofen - regular release forms

Criteria Approval Period
1. Diagnosis of rheumatoid or psoriatic arthritis or ankylosing spondylitis or gout or lupus.

OR

2. Treatment failure or intolerance to at least one of the following: ASA-enteric, naproxen, or ibuprofen.

 Indefinite

Practitioner Exemptions

  • Rheumatologists

Special Notes

  • Group 2 NSAID
  • Coverage for flurbiprofen 200mg sustained release product is subject to further limitations. Full coverage is only provided for individuals who have documented breakthrough symptoms while on the regular release form for a trial period. Full coverage is not provided for dosage convenience.

Online Form (PDF)
Click on the link to complete a special authority request form.

PDF Format

Some documents on this Web site are in PDF format and require a PDF reader. If you do not have Adobe Acrobat Reader Version 7.0 or the most recent version of another PDF reader, you can download Adobe Acrobat Reader by selecting the 'Get Acrobat Reader' icon. Get Acrobat Reader Icon

Back To Top

Last Revised: June 21, 2006

blank space for alignment
Go to TopGo to CopyrightGo to DisclaimerGo to Privacy StatementGo to Feedback Form
blank space for alignment blank space for alignment blank space for alignment blank space for alignment blank space for alignment blank space for alignment